Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.
European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.
Investigative and Clinical Urology|June 30, 2021
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort studyArnas Rakauskas, Thomas Tawadros, Ilaria Lucca, et al.
World Journal of Urology|January 28, 2026
How safe is teaching radical cystectomy? : Results from the prospective Swiss society of urology databaseMatteo Scherrer, Lujza Brunaiova, Marc Furrer, et al.
World Journal of Urology|February 17, 2016
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinomaHarun Fajkovic, Shahrokh F Shariat, Tobias Klatte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2016
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer PatientsLaurent Derré, Valérie Cesson, Ilaria Lucca, et al.
Pageof 9